Zhejiang HISUN Biomaterials Co. Ltd. A (SHG:688203) — Market Cap & Net Worth
Market Cap & Net Worth: Zhejiang HISUN Biomaterials Co. Ltd. A (688203)
Zhejiang HISUN Biomaterials Co. Ltd. A (SHG:688203) has a market capitalization of $524.06 Million (CN¥3.58 Billion) as of September 21, 2026. Listed on the SHG stock exchange, this China-based company holds position #12115 globally and #3511 in its home market, demonstrating a 20.78% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang HISUN Biomaterials Co. Ltd. A's stock price CN¥17.67 by its total outstanding shares 202678068 (202.68 Million). Also see 688203 total assets for a full breakdown of the balance sheet.
Zhejiang HISUN Biomaterials Co. Ltd. A Market Cap History: 2022 to 2026
Zhejiang HISUN Biomaterials Co. Ltd. A's market capitalization history from 2022 to 2026. Data shows change from $458.42 Million to $524.06 Million (-3.67% CAGR). Also see Zhejiang HISUN Biomaterials Co. Ltd. A operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Zhejiang HISUN Biomaterials Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang HISUN Biomaterials Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 688203 live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.34x
Zhejiang HISUN Biomaterials Co. Ltd. A's market cap is 0.34 times its annual revenue
Latest Price to Earnings (P/E) Ratio
8.14x
Zhejiang HISUN Biomaterials Co. Ltd. A's market cap is 8.14 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $458.42 Million | $605.43 Million | $47.04 Million | 0.76x | 9.75x |
| 2023 | $383.17 Million | $753.32 Million | $43.55 Million | 0.51x | 8.80x |
| 2024 | $288.87 Million | $845.19 Million | $35.50 Million | 0.34x | 8.14x |
Competitor Companies of 688203 by Market Capitalization
Companies near Zhejiang HISUN Biomaterials Co. Ltd. A in the global market cap rankings as of September 21, 2026. Review 688203 tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Zhejiang HISUN Biomaterials Co. Ltd. A by market ranking:
- BASF SE (F:BASA): Ranked #598 globally with a market cap of $45.63 Billion USD ( €39.03 Billion EUR).
- BASF SE (XETRA:BAS): Ranked #616 globally with a market cap of $44.62 Billion USD ( €38.17 Billion EUR).
- Ningxia Baofeng Energy Group Co Ltd (SHG:600989): Ranked #1068 globally with a market cap of $25.31 Billion USD ( CN¥172.99 Billion CNY).
- Dow Inc (NYSE:DOW): Ranked #1247 globally with a market cap of $20.71 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #598 | BASF SE | F:BASA | $45.63 Billion | €12.70 |
| #616 | BASF SE | XETRA:BAS | $44.62 Billion | €51.62 |
| #1068 | Ningxia Baofeng Energy Group Co Ltd | SHG:600989 | $25.31 Billion | CN¥23.59 |
| #1247 | Dow Inc | NYSE:DOW | $20.71 Billion | $28.73 |
Zhejiang HISUN Biomaterials Co. Ltd. A Historical Marketcap From 2022 to 2026
Between 2022 and today, Zhejiang HISUN Biomaterials Co. Ltd. A's market cap moved from $458.42 Million to $ 524.06 Million, with a yearly change of -3.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥524.06 Million | +38.26% |
| 2025 | CN¥379.03 Million | +31.21% |
| 2024 | CN¥288.87 Million | -24.61% |
| 2023 | CN¥383.17 Million | -16.41% |
| 2022 | CN¥458.42 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 21st, 2026 the market cap of Zhejiang HISUN Biomaterials Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $524.06 Million USD |
| MoneyControl | $524.06 Million USD |
| MarketWatch | $524.06 Million USD |
| marketcap.company | $524.06 Million USD |
| Reuters | $524.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang HISUN Biomaterials Co. Ltd. A
Zhejiang Hisun Biomaterials Co.Ltd. engages in the research, development, production, and sale of polylactic acid in China. The company's products are used in various applications that include 3D printing, extrusion, thermoforming, film and laminating, injection molding, non-woven fabric, and injection blow molding. Zhejiang Hisun Biomaterials Co.Ltd. was founded in 2004 and is based in Taizhou, … Read more